Cite
MLA Citation
María‐Victoria Mateos et al.. “Elotuzumab in combination with thalidomide and low‐dose dexamethasone: a phase 2 single‐arm safety study in patients with relapsed/refractory multiple myeloma.” British journal of haematology, vol. 175, 2016, pp. 448–456. http://access.bl.uk/ark:/81055/vdc_100038938787.0x000060